Superior Planning LLC’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$538 Buy
+46
New +$752 ﹤0.01% 1880

Other funds holding MLTX

Superior Planning LLC's MLTX Position: Q3 2026 in Review

Superior Planning LLC opened a new position in MoonLake Immunotherapeutics (MLTX) in Q3 2026: 46 shares worth $538. The stake represents ﹤0.01% of the portfolio and ranks #1880 among its holdings.

106 funds tracked by Wall St. Rank hold MLTX as of Q3 2026.

  • Superior Planning LLC held 46 shares of MoonLake Immunotherapeutics worth $538 as of Q3 2026.
  • MoonLake Immunotherapeutics was a new Superior Planning LLC position in Q3 2026.
  • MoonLake Immunotherapeutics made up ﹤0.01% of Superior Planning LLC's portfolio in Q3 2026, its #1880 holding.
  • 106 funds tracked by Wall St. Rank held MoonLake Immunotherapeutics as of Q3 2026.

Based on Superior Planning LLC's 13F filing for Q3 2026, filed 12 Nov 2026.